Inhibition of GPX4 enhances CDK4/6 inhibitor activity in breast cancer

被引：0
|
作者：
Abreu, Maria Teresa Herrera
Khalid, Uzma
Ning, Jian
Cutts, Rosalind
Wilson, Gemma
Lord, Christopher
Swain, Amanda
Turner, Nicholas
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS12-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS12-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer
    Herrera-Abreu, M. T.
    Guan, J.
    Khalid, U.
    Ning, J.
    Costa, M. R.
    Chan, J.
    Li, Q.
    Fortin, J-p.
    Wong, W. R.
    Perampalam, P.
    Biton, A.
    Sandoval, W.
    Vijay, J.
    Hafner, M.
    Cutts, R.
    Wilson, G.
    Frankum, J.
    Roumeliotis, T. I.
    Alexander, J.
    Hickman, O.
    Brough, R.
    Haider, S.
    Choudhary, J.
    Lord, C. J.
    Swain, A.
    Metcalfe, C.
    Turner, N. C.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [2] MGMT inhibition leads to CDK4/6 inhibition and enhances palbociclib and abemaciclib activity in breast cancer
    Bobustuc, George C.
    Kassam, Amin B.
    Rovin, Richard A.
    Donohoe, Deborah L.
    Albiero, Maxwell
    Jella, Tarun
    Fukui, Olivia
    Piron, Cameron
    Konduri, Santhi D.
    CANCER RESEARCH, 2017, 77
  • [3] The Role of CDK4/6 Inhibition in Breast Cancer
    Murphy, Conleth G.
    Dickler, Maura N.
    ONCOLOGIST, 2015, 20 (05): : 483 - U49
  • [4] CDK4/6 inhibition in luminal breast cancer
    Gampenrieder S.P.
    Rinnerthaler G.
    Greil R.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 76 - 81
  • [5] Clinical development of CDK4/6 inhibitor for breast cancer
    Iwata, Hiroji
    BREAST CANCER, 2018, 25 (04) : 402 - 406
  • [6] Clinical development of CDK4/6 inhibitor for breast cancer
    Hiroji Iwata
    Breast Cancer, 2018, 25 : 402 - 406
  • [7] Mechanisms of therapeutic CDK4/6 inhibition in breast cancer
    Scott, Susan Combs
    Lee, Sarah S.
    Abraham, Jame
    SEMINARS IN ONCOLOGY, 2017, 44 (06) : 385 - 394
  • [8] Combination CDK4/6 inhibition and AR agonism suppresses the growth of CDK4/6 inhibitor resistant breast cancers
    Freelander, Allegra
    Laven-Law, Geraldine
    Eshraghi, Leila
    Chia, Kee Ming
    Pickering, Marie
    Yong, Aliza
    Wilkinson, Ashleigh
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Hickey, Theresa E.
    Tilley, Wayne D.
    Lim, Elgene
    CANCER RESEARCH, 2022, 82 (04)
  • [9] CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard
    Wolff, Antonio C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20): : 1993 - 1995
  • [10] Therapeutic targeting of CDK4/6 inhibitor resistant breast cancer
    Lim, Elgene
    Portman, Neil
    Alexandrou, Sarah
    Haupt, Susan
    Haupt, Ygal
    Caldon, Elizabeth
    CANCER RESEARCH, 2018, 78 (04)
12345